PeptidePedia
Experimental

Epitalon

A four-amino-acid peptide studied primarily in Russian and Eastern European research for longevity, sleep, and antioxidant effects.

In plain English

Epitalon (also called epithalon) is a tetrapeptide (Ala-Glu-Asp-Gly) developed in the 1980s by Vladimir Khavinson and colleagues in St. Petersburg, Russia. It is a synthetic analog of a polypeptide extract from the pineal gland (epithalamin). Most published work is in Russian-language journals or small Russian-led trials, with claims around telomere maintenance, melatonin secretion, sleep, and life-span extension. Outside that body of research, mainstream Western RCT evidence is essentially absent. Epitalon is not FDA-approved.

What it is

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on a polypeptide fraction of the pineal gland.

Mechanism (summary)

Proposed mechanisms include activation of telomerase, modulation of pineal melatonin secretion, and influence on circadian and neuroendocrine signaling. The molecular basis is not well-characterized in mainstream literature.

Why people research it

  • Telomere length and cellular aging
  • Sleep and melatonin secretion
  • Antioxidant signaling
  • Age-related decline in pineal function

Human evidence

Small, mostly Russian-language clinical reports in older adults describe improvements in sleep architecture, melatonin patterns, and select clinical endpoints. Mainstream peer-reviewed RCTs in English-language journals are essentially absent.

Animal / lab evidence

Rodent studies from the Khavinson group describe extended median life span, reduced spontaneous tumor incidence, and antioxidant effects.

Key studies

Each summary explains the design, what was found, and what it doesn't prove.

Review2002·Review of animal and small human studies
Peptides and Aging — Khavinson review

A review by the lab that developed epitalon, summarizing decades of their own animal and small human work on it.

Finding: Summarizes a body of work attributing antitumor, life-span, and circadian effects to short peptides including epitalon.
Limitations: Most underlying studies come from a single research group and are not independently replicated at scale.
Animal2000·Animals and small human cohort
Effects of pineal peptide preparation Epithalamin on free radical processes in humans and animals

Pineal peptide preparations seemed to lower oxidative-stress markers in animals and small human groups.

Finding: Pineal peptide preparations were associated with reductions in oxidative-stress markers.
Limitations: Small cohorts; older methodology; results not widely replicated.

History

Developed by Vladimir Khavinson in the 1980s as part of the broader 'cytomedines' / short-peptide bioregulator research program at the St. Petersburg Institute of Bioregulation and Gerontology.

Important:

PeptidePedia is for educational and informational purposes only. We do not sell peptides, prescribe peptides, provide medical advice, or recommend treatment. Peptides may not be approved for human use except in specific legal prescription or clinical contexts. Always consult a licensed medical professional before making health decisions.

Related peptides